Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Korean Society Of Hematology

Clinical trials sponsored by Korean Society Of Hematology, explained in plain language.

Trials to join now! 1

New hope for CML patients: drug combo aims for Drug-Free remission

Disease control Recruiting now

This study tests whether adding asciminib to standard tyrosine kinase inhibitors (TKIs) can help people with chronic myeloid leukemia (CML) safely stop all medication and stay in remission. It includes 69 adults who have been on TKIs for at least 5 years and previously failed to …

Phase: PHASE2 • Sponsor: Korean Society of Hematology • Aim: Disease control

Last updated May 22, 2026 13:52 UTC